The healthcare world is observing a remarkable shift in glucose therapy with the emergence of GLP-1 transdermal devices. These systems offer a potentially more comfortable alternative to injections of GLP-1 receptor agonists, minimizing the frequency of daily needle sticks. The approach delivers